Cite
HARVARD Citation
Foà, R. et al. (n.d.). Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients. American journal of hematology. 89 (5), pp. 480-486. [Online].